Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
biospatial
AddedFeb 15, 2024
UpdatedJun 18, 2026
biospatial

biospatial

Series A

Biospatial: A data analysis platform leveraging AI to improve patient outcomes by analyzing prehospital data across the US.

HQ
Durham, NC, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to enhance patient outcomes through data-driven insights, Biospatial offers a cutting-edge platform that aggregates and analyzes prehospital data. By partnering with state and local Emergency Medical Services (EMS) agencies, Biospatial collects electronic Patient Care Reports (ePCR) and employs machine learning and artificial intelligence to provide actionable insights. Their services cater to both public sector and commercial healthcare entities, focusing on faster decision-making, informed engagement, and improved healthcare outcomes.

Biospatial has garnered attention for its innovative use of AI in healthcare data analysis, attracting notable investors and affiliations within the healthcare technology sector. The platform's ability to aggregate data from thousands of EMS providers has established it as a leader in prehospital data analysis. Key achievements include the development of state and national EMS trends and performance benchmarks, significantly impacting the efficiency and effectiveness of emergency medical services across the United States.

biospatial - Similar Companies

Beyond Lucid Technologies logo

Beyond Lucid Technologies

beyondlucid.com

BioSignal Analytics logo

BioSignal Analytics

Pivotal Analytics logo

Pivotal Analytics

Empericus logo

Empericus

Orbital Insight logo

Orbital Insight

orbitalinsight.com

HealthTrends.AI logo

HealthTrends.AI

healthtrends.ai

Limmi logo

Limmi

limmi.io

Spatial logo

Spatial

spatialabs.io

Bayesian Health logo

Bayesian Health

bayesianhealth.com

Spatio Metrics logo

Spatio Metrics

Bonfire Analytics logo

Bonfire Analytics

Verana Health logo

Verana Health

veranahealth.com

Biome Analytics logo

Biome Analytics

biome.io

PotentiaMetrics logo

PotentiaMetrics

Real Time Medical Systems logo

Real Time Medical Systems

biospatial - Quick Facts

Who are biospatial's competitors?

Companies similar to biospatial include Beyond Lucid Technologies, BioSignal Analytics, Pivotal Analytics and Empericus.

When was biospatial founded?

biospatial was founded in 2017.

Where is biospatial's headquarters located?

biospatial's headquarters is located in Durham, NC, US.

When was biospatial's last funding round?

biospatial's most recent funding round was for $3.4M (USD) in May 2022.

How much has biospatial raised to-date?

As of May 27, 2022, biospatial has raised a total of $6.8M (USD).

How many employees does biospatial have?

biospatial has 19 employees as of Feb 5, 2024.

biospatial - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • SaaS
Customer
  • Enterprise
  • Government
Main Product
  • Data Analytics
Tags
  • Data
  • Healthtech
NAICS
  • 518000Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
  • 518200Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
  • 510000Information
  • 518210Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
Show 3 more industry codes
NAICS
  • 513200Software Publishers
  • 513000Publishing Industries
  • 513210Software Publishers